Vivimed Labs exports Famotidine tablets to Canada
The tablets are being manufactured in the company's Hyderabad site which is approved by Health Canada, Vivimed Labs said.
New Delhi: Drug firm Vivimed Labs on Monday said it has exported the first shipment of Famotidine tablets that work by decreasing the amount of acid in the stomach, to Canada.
The export is for tablets in the strengths of 40mg and 20mg, Vivimed Labs said in a regulatory filing.
“Successful launch of Famotidine is a demonstration of Vivimed’s contract development and manufacturing organisation (CDMO) capability to the Canada market in collaboration with a strategic partner,” Vivimed Labs CEO Ramesh Krishnamurthy said.
This sets the stage for a new range of CDMO products. In the next six months, Vivimed will continue to leverage capabilities to expand its COMO footprint, he added.
The tablets are being manufactured in the company’s Hyderabad site which is approved by Health Canada, Vivimed Labs said.
Famotidine tablets are used for the relief of heartburn, indigestion, upset stomach, sour stomach due to excess stomach acid, hyperacidity and/or acid indigestion.
Shares of Vivimed Labs were trading at Rs 29.65 per scrip on BSE, up 4.77 percent from its previous close.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
